Orthopedic Surgery · Russellville, AL
NPI
1154313807
Since 2005
Specialty
Orthopedic Surgery
Code 207X00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
101 James Hovater Rd
Russellville, AL, 35653
Phone (256) 332-6208
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
17,694 services
Medicare patients, 2024
267
Average age 70
Drug cost, 2024
$290K
13,959 prescriptions
Company payments, 2025
$747
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lloyd C Dyas was code J1010 (injection, methylprednisolone acetate, 1 mg), 15,937 times for 97 patients. In total Lloyd C Dyas billed 17,694 services in 76 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 15,937 | 97 | $0.10 | $1,577 |
| 99214 Office E&M - Established | Office | 520 | 219 | $84.92 | $44K |
| 80305 Drug Tests | Office | 308 | 178 | $12.25 | $3,772 |
| 99213 Office E&M - Established | Office | 151 | 112 | $51.36 | $7,756 |
| 20552 Musculoskeletal | Office | 112 | 45 | $30.94 | $3,466 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 103 | 37 | $4.48 | $461 |
| 20610 Joint Injection | Office | 92 | 44 | $42.10 | $3,873 |
| 96372 Injection Administration | Office | 53 | 38 | $9.66 | $512 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 45 | 36 | $0.09 | $3.9 |
| 73562 X-ray - Lower Extremity | Office | 41 | 37 | $23.46 | $962 |
| 73030 X-ray - Upper Extremity | Office | 40 | 34 | $23.61 | $945 |
| 73501 X-ray - Lower Extremity | Office | 24 | 16 | $21.91 | $526 |
| 99203 Office E&M - New | Office | 20 | 20 | $64.05 | $1,281 |
| 72100 X-ray - Spine and Pelvis | Office | 19 | 19 | $26.35 | $501 |
| 73620 X-ray - Lower Extremity | Office | 13 | 11 | $16.73 | $218 |
By year: 2022 $156K for 2,335 services; 2023 $125K for 1,901 services; 2024 $117K for 17,694 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 308 | 178 | $12.25 | $3,772 |
Medicare prescription drug claims, 2024
In 2024, the drug Lloyd C Dyas prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 5,380 prescriptions and refills. In total Lloyd C Dyas wrote 13,959 Medicare prescriptions that cost $290K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 5,380 | 5,386 | 542 | $143K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,806 | 1,806 | 213 | $50K |
| Gabapentin Generic | 1,562 | 1,578 | 174 | $15K |
| Ibuprofen Generic | 715 | 715 | 139 | $7,290 |
| Cyclobenzaprine Hcl Generic | 591 | 593 | 88 | $3,024 |
| Tizanidine Hcl Generic | 566 | 574 | 92 | $4,156 |
| Pregabalin Generic | 548 | 555 | 65 | $7,926 |
| Oxycodone Hcl Generic | 370 | 370 | 41 | $6,962 |
| Methocarbamol Generic | 297 | 297 | 49 | $2,587 |
| Diclofenac Sodium Generic | 245 | 245 | 43 | $9,150 |
| Meloxicam Generic | 191 | 192 | 35 | $408 |
| Baclofen Generic | 179 | 190 | 28 | $1,254 |
| Tramadol Hcl Generic | 123 | 123 | 24 | $1,027 |
| Celecoxib Generic | 120 | 124 | 21 | $1,530 |
| Methylprednisolone Generic | 91 | 91 | 68 | $768 |
Brand drugs: - claims; generic drugs: 13,856 claims; opioid claims: 7,789.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lloyd C Dyas $747 ($747 in general payments such as food, travel and fees) from 4 companies. The largest payer was Stryker Corporation with $560.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.